SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms

Front Immunol. 2021 May 10:12:674922. doi: 10.3389/fimmu.2021.674922. eCollection 2021.

Abstract

Since December 2019, the world has been facing an outbreak of a new disease called coronavirus disease 2019 (COVID-19). The COVID-19 pandemic is caused by a novel beta-coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 infection mainly affects the respiratory system. Recently, there have been some reports of extra-respiratory symptoms such as neurological manifestations in COVID-19. According to the increasing reports of Guillain-Barré syndrome following COVID-19, we mainly focused on SARS-CoV-2 infection and Guillain-Barré syndrome in this review. We tried to explain the possibility of a relationship between SARS-CoV-2 infection and Guillain-Barré syndrome and potential pathogenic mechanisms based on current and past knowledge.

Keywords: COVID-19; Coronavirus; Guillain-Barré syndrome; Neurological manifestations; SARS-CoV-2.

Publication types

  • Review

MeSH terms

  • COVID-19 / complications*
  • COVID-19 / epidemiology
  • COVID-19 / immunology
  • COVID-19 / pathology
  • Guillain-Barre Syndrome / epidemiology
  • Guillain-Barre Syndrome / etiology*
  • Guillain-Barre Syndrome / immunology
  • Guillain-Barre Syndrome / pathology
  • Humans
  • Nervous System Diseases / epidemiology
  • Nervous System Diseases / etiology
  • Nervous System Diseases / immunology
  • Nervous System Diseases / pathology
  • SARS-CoV-2 / pathogenicity*
  • Virulence